申请人:Vida Pharma Limited
公开号:US10842784B2
公开(公告)日:2020-11-24
Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.
所描述的是包含亚氨基糖酸的组合物,用于治疗能量利用疾病(例如代谢综合征,包括与之相关的任何疾病或紊乱,例如中心性肥胖、甘油三酯水平升高和糖尿病,包括 1 型糖尿病、2 型糖尿病和胰岛素抵抗);从各种植物来源生产所述组合物的工艺,以及基于此的各种产品、化合物、组合物、医疗用途和方法。